Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients
SED_ICU
1 other identifier
interventional
174
1 country
2
Brief Summary
Sedation and analgesia are fundamental tools for managing critical patients who require mechanical ventilation. However, recent scientific literature highlights that excessive sedation in these patients can increase the duration of mechanical ventilation and extend the overall length of stay in intensive care, as well as expose them to a higher risk of hypotension, venous thrombosis, and nosocomial pneumonia. The titration of sedation and analgesia in intensive care, on the other hand, is currently based primarily on clinical parameters (such as the onset of delirium, asynchronies with the ventilator, for example), which can lead to treatments not proportionate to the patient's needs. The present study aims to evaluate the application, in an intensive care setting, of the Conox® system, a device already widely used in monitoring the anesthetic plan in the operating room. This tool would allow, through the processing of an EEG trace, the assessment of the level of sedation (qCON) and the probable algic response (qNOX), thus providing valuable information for the fine-tuning of the analgo-sedative plan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 23, 2024
CompletedFirst Posted
Study publicly available on registry
January 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2027
January 10, 2025
July 1, 2024
3 years
July 23, 2024
January 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ventilator free days
The number of days without ventilation
Day 28
Secondary Outcomes (3)
Delirium occurrence
Daily after extubation
ICU lenght of stay
ICU discharge
Drug consumption
ICU discharge
Study Arms (2)
Standard of care sedation
ACTIVE COMPARATORThe patients will be sedated according to the current standard of care (Behavioral pain scale and Richmond Agitation-Sedation Scale).
EEG guided sedation
EXPERIMENTALThe patients will be sedated according to the EEG derived indexes (qCON/qNOX).
Interventions
Sedation will be titrated according to the EEG derived indexes (qCON/qNOX)
Sedation will be provided according to the standard of care of the unit (clinical scales)
Eligibility Criteria
You may qualify if:
- Age 18-90 years Admission to the ICU for less than 24 hours Expected mechanical ventilation for \>48 hours Ongoing sedation
You may not qualify if:
- Mechanical ventilation (MV) for less than 48 hours Patient or next of kin refusal to participate BMI \> 35 Cerebrovascular disease Scheduled surgery Neuromuscular disease Presence of craniofacial trauma that prevents the placement of electrodes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Università degli Studi di Ferraralead
- Arcispedale S. Anna, Ferraracollaborator
Study Sites (2)
Azienda Ospedaliera Universitaria Sant'Anna
Ferrara, Italy, 44100, Italy
Azienda Ospedaliera Universitaria Federico II - "Policlinico"
Napoli, Napoli, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 23, 2024
First Posted
January 10, 2025
Study Start
January 1, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
July 31, 2027
Last Updated
January 10, 2025
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share